Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases.
interventional radiology
liver metastases
locoregional therapy
uveal melanoma
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
24 May 2023
24 May 2023
Historique:
received:
22
03
2023
revised:
01
05
2023
accepted:
12
05
2023
medline:
10
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Uveal melanoma is one of the most common primary intraocular malignancies that accounts for about 85% of all ocular melanomas. The pathophysiology of uveal melanoma is distinct from cutaneous melanoma and has separate tumor profiles. The management of uveal melanoma is largely dependent on the presence of metastases, which confers a poor prognosis with a one-year survival reaching only 15%. Although a better understanding of tumor biology has led to the development of novel pharmacologic agents, there is increasing demand for minimally invasive management of hepatic uveal melanoma metastases. Multiple studies have already summarized the systemic therapeutic options available for metastatic uveal melanoma. This review covers the current research for the most prevalent locoregional treatment options for metastatic uveal melanoma including percutaneous hepatic perfusion, immunoembolization, chemoembolization, thermal ablation, and radioembolization.
Identifiants
pubmed: 37296688
pii: diagnostics13111836
doi: 10.3390/diagnostics13111836
pmc: PMC10253082
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Front Chem. 2019 Jun 05;7:408
pubmed: 31231636
Melanoma Res. 2005 Aug;15(4):297-304
pubmed: 16034309
Cardiovasc Intervent Radiol. 2020 Feb;43(2):254-263
pubmed: 31686137
Cancer Control. 2020 Jan-Dec;27(1):1073274820983019
pubmed: 33372814
Phys Med. 2019 Dec;68:132-145
pubmed: 31785502
Radiology. 2009 Jul;252(1):290-8
pubmed: 19561263
Diagn Interv Radiol. 2012 Sep-Oct;18(5):508-16
pubmed: 22407695
Cancers (Basel). 2022 Feb 24;14(5):
pubmed: 35267470
Cancers (Basel). 2021 Dec 27;14(1):
pubmed: 35008282
Melanoma Res. 2020 Jun;30(3):252-260
pubmed: 31895753
Cancer Invest. 2009 Jul;27(6):682-90
pubmed: 19219675
AJR Am J Roentgenol. 2015 May;204(5):W495-502
pubmed: 25905955
Commun Med (Lond). 2022 Mar 1;2:18
pubmed: 35603296
Gut. 2022 Jul;71(7):1386-1398
pubmed: 34413131
J Vasc Interv Radiol. 2015 Apr;26(4):523-32.e2
pubmed: 25678394
Cardiovasc Intervent Radiol. 2018 Jul;41(7):1043-1048
pubmed: 29675772
Int J Mol Sci. 2021 Jun 15;22(12):
pubmed: 34203771
J Vasc Interv Radiol. 2017 Mar;28(3):325-333
pubmed: 28073607
J Clin Oncol. 2008 Nov 20;26(33):5436-42
pubmed: 18838710
AJR Am J Roentgenol. 2015 Aug;205(2):429-33
pubmed: 25905562
HPB (Oxford). 2020 Apr;22(4):497-505
pubmed: 31791894
BMC Cancer. 2019 Nov 29;19(1):1162
pubmed: 31783814
PLoS One. 2022 Jan 13;17(1):e0261939
pubmed: 35025911
Front Oncol. 2022 Sep 08;12:961517
pubmed: 36212499
BMC Cancer. 2018 Aug 15;18(1):821
pubmed: 30111304
Cancer. 2005 Oct 15;104(8):1590-602
pubmed: 16134179
Front Immunol. 2022 Jul 05;13:901277
pubmed: 35865534
J Vasc Interv Radiol. 2018 Oct;29(10):1369-1375
pubmed: 30174161
J Surg Oncol. 2015 Jun;111(8):962-8
pubmed: 26073980
Cardiovasc Intervent Radiol. 2013 Feb;36(1):158-65
pubmed: 22526099
Melanoma Manag. 2019 Sep 02;6(3):MMT26
pubmed: 31807277
PLoS One. 2015 Apr 07;10(4):e0123065
pubmed: 25849963
Radiol Imaging Cancer. 2021 Feb 12;3(2):e200101
pubmed: 33817650
Semin Intervent Radiol. 2020 Dec;37(5):508-517
pubmed: 33328707
Nat Rev Clin Oncol. 2023 Feb;20(2):99-115
pubmed: 36600005
AJR Am J Roentgenol. 2011 Feb;196(2):468-73
pubmed: 21257902
Hepatology. 2015 May;61(5):1579-90
pubmed: 25284802
Ann Surg Oncol. 2016 Apr;23(4):1309-19
pubmed: 26597368
Cardiovasc Intervent Radiol. 2016 Sep;39(9):1289-97
pubmed: 27343124
Lancet Gastroenterol Hepatol. 2018 May;3(5):317-325
pubmed: 29503247
Cardiovasc Intervent Radiol. 2010 Jun;33(3):541-51
pubmed: 19937027
Surg Endosc. 2016 Jun;30(6):2567-71
pubmed: 26310535
Sci Rep. 2022 Jan 10;12(1):316
pubmed: 35013377
Cancer Biother Radiopharm. 2022 Feb;37(1):11-16
pubmed: 35021863
Cancers (Basel). 2022 Jun 23;14(13):
pubmed: 35804863
Acta Oncol. 2018 Oct;57(10):1373-1380
pubmed: 29683787
J Clin Oncol. 2005 May 20;23(15):3465-74
pubmed: 15908655
Br J Ophthalmol. 2023 Mar;107(3):406-411
pubmed: 34880052
Eur J Surg Oncol. 2019 Sep;45(9):1717-1722
pubmed: 31266665
Surg Today. 2013 Apr;43(4):367-71
pubmed: 22766897
World J Radiol. 2013 Jan 28;5(1):1-4
pubmed: 23493926
Radiology. 2019 Oct;293(1):223-231
pubmed: 31453767
Radiology. 2019 Jul;292(1):25-34
pubmed: 31012818
J Clin Transl Hepatol. 2014 Sep;2(3):182-8
pubmed: 26355719
J Surg Oncol. 2018 May;117(6):1170-1178
pubmed: 29284076
Br J Ophthalmol. 2017 Jan;101(1):38-44
pubmed: 27574175
Cancer Immunol Immunother. 2020 Sep;69(9):1713-1724
pubmed: 32333081
Medicine (Baltimore). 2019 May;98(21):e15314
pubmed: 31124925
Semin Radiat Oncol. 2011 Oct;21(4):294-302
pubmed: 21939859
Eur J Surg Oncol. 2016 May;42(5):706-12
pubmed: 26968227
Melanoma Res. 2010 Jun;20(3):191-6
pubmed: 20335820
JAMA. 1988 Aug 19;260(7):974-6
pubmed: 3398202
Am J Clin Oncol. 2010 Oct;33(5):474-80
pubmed: 19935383
J Clin Anesth. 2022 May;77:110641
pubmed: 34954556
Eur J Radiol. 2010 Jun;74(3):e38-44
pubmed: 19467811